Sacramento, CANCT06746883Now EnrollingIRB Ready

Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC) Clinical Trial in Sacramento, CA

Access cutting-edge acinetobacter baumannii-calcoaceticus complex infection (abc) treatment through this clinical trial at a research site in Sacramento. Study-provided care at no cost to qualified participants.

Sponsored by Innoviva Specialty Therapeutics

Quick Self-Assessment

See if you qualify for this Sacramento location

Preparing your pre-screening questions…

Expert Care in Sacramento

Access acinetobacter baumannii-calcoaceticus complex infection (abc) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related acinetobacter baumannii-calcoaceticus complex infection (abc) treatment provided free

Apply for This Sacramento Location

Check if you qualify for this acinetobacter baumannii-calcoaceticus complex infection (abc) clinical trial in Sacramento, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Sacramento

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Sacramento site if eligible
  4. 4Begin participation

About This Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC) Study in Sacramento

The goal of this observational study is to evaluate the safety of sulbactam-durlobactam, as well as the risk of hypersensitivity reactions (including anaphylaxis) in participants with Acinetobacter baumannii-calcoaceticus complex infection. Participants will be followed for approximately 28 days in order to collect safety and reaction data.

Sponsor: Innoviva Specialty Therapeutics

Who Can Participate

Inclusion Criteria

Participant is ≥18 years old at the time of written informed consent and is hospitalized.
Participant has provided the written informed consent. If a participant is unable to provide written informed consent due to their medical condition, the participant's legally authorized representative may consent on behalf of the participant, or the decision can be made according to the procedure permitted by local law and institutional standard operating procedures (SOPs).
Participant has a proven or strongly suspected diagnosis of an infection caused by susceptible ABC isolates, based on investigator's clinical judgment.
Participant initiates treatment with SUL-DUR per routine clinical care. Participants who receive SUL-DUR within 24 hours prior to enrollment are also eligible to participate. The decision to treat the participant with SUL-DUR is made prior to and independently of study participation.
The participant has an expected survival of \>48 hours at the time of written informed consent.

Exclusion Criteria

A history of significant hypersensitivity or allergic reaction to any β-lactam, or any contraindication to the use of β-lactam antibiotics

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Sacramento?

Yes, this clinical trial (NCT06746883) has an active research site in Sacramento, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC) Treatment Options in Sacramento, CA

If you're searching for acinetobacter baumannii-calcoaceticus complex infection (abc) treatment options in Sacramento, CA, this clinical trial (NCT06746883) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Sacramento research site is actively enrolling participants for this clinical trial. You'll receive care from experienced acinetobacter baumannii-calcoaceticus complex infection (abc) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all acinetobacter baumannii-calcoaceticus complex infection (abc) clinical trials near you to find additional studies recruiting in your area.

More Neuroendocrine Tumors Trials in Sacramento, CA

See all neuroendocrine tumors clinical trials recruiting in Sacramento — not just this study.

Browse Neuroendocrine Tumors Trials in Sacramento →

Browse More Trials by Condition

Neuroendocrine Tumors TrialsEssential Tremor TrialsInterstitial Cystitis TrialsOsteoarthritis TrialsAll Conditions →

Ready to Join in Sacramento?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Sacramento, CA